{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:13:16Z","timestamp":1793722396696,"version":"4.6.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T00:00:00Z","timestamp":1637539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>Cancer will soon become the leading cause of death in every country in the twenty-first century. This study aimed to analyze the mortality and morbidity of 29 types of cancer in 204 countries or regions from 1990 to 2019 to guide global cancer prevention and control.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Detailed information for 29 cancer groups was collected from the Global Burden of Disease Study in 2019. The age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR) of the 29 cancer groups were calculated based on sex, age, region, and country. In addition, separate analyses were performed for major cancer types.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 2019, more than 10 million people died from cancer, which was approximately twice the number in 1990. Tracheal, bronchus, and lung (TBL) cancers collectively showed the highest death rate, and the ASDR of pancreatic cancer increased by 24%, which was cancer with the highest case fatality rate (CFR). The global cancer ASIR showed an increasing trend, with testicular cancer, thyroid cancer, and malignant skin melanoma showing a significant increase. The ASDR and ASIR of cancer in males were about 1.5 times higher than that in females. Individuals over 50\u00a0years had the highest risk of developing cancer, with incidences and deaths in this age group accounting for more than 85% of cancers in all age groups. Asia has the heaviest cancer burden due to its high population density, with esophageal cancer in this region accounting for 53% of the total fatalities related to this type of cancer in the world. In addition, the mortality and morbidity of most cancers increased with the increase in the development or socio-demographic index (SDI) in the SDI regions based on the World Bank's Human Development Index (HDI), with cancer characteristics varying in the different countries globally.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The global cancer burden continues to increase, with substantial mortality and morbidity differences among the different regions, ages, countries, gender, and cancer types. Effective and locally tailored cancer prevention and control measures are essential in reducing the global cancer burden in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13045-021-01213-z","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T10:02:57Z","timestamp":1637575377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":317,"title":["Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990\u20132019"],"prefix":"10.1186","volume":"14","author":[{"given":"Longfei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9482-6716","authenticated-orcid":false,"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,22]]},"reference":[{"key":"1213_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1213_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13045-019-0783-9","volume":"12","author":"L Lin","year":"2019","unstructured":"Lin L, Yan L, Liu Y, Yuan F, Li H, Ni J. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study. J Hematol Oncol. 2019;12:96.","journal-title":"J Hematol Oncol"},{"key":"1213_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study. Lancet Oncol. 2012;13:790\u2013801.","journal-title":"Lancet Oncol"},{"key":"1213_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13045-019-0828-0","volume":"12","author":"N Li","year":"2019","unstructured":"Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019;12:140.","journal-title":"J Hematol Oncol"},{"key":"1213_CR5","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2020. http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"key":"1213_CR6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Global Burden of Disease Cancer Center, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749\u201368.","journal-title":"JAMA Oncol"},{"key":"1213_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Global Burden of Disease Cancer Center, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524\u201348.","journal-title":"JAMA Oncol"},{"key":"1213_CR8","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","volume":"4","author":"C Fitzmaurice","year":"2018","unstructured":"Global Burden of Disease Cancer Center, Fitzmaurice C, Akinyemiju TF, Al Lami FH, Alam T, Alizadeh-Navaei R, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553\u201368.","journal-title":"JAMA Oncol"},{"key":"1213_CR9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBD 2016 Dementia Collaborators","year":"2020","unstructured":"GBD 2016 Dementia Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1160\u2013203.","journal-title":"Lancet"},{"key":"1213_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"GBD Diseases","year":"2020","unstructured":"Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","journal-title":"Lancet"},{"key":"1213_CR11","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/cas.12821","volume":"106","author":"M Watanabe","year":"2015","unstructured":"Watanabe M, Ito H, Hosono S, Oze I, Ashida C, Tajima K, et al. Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population. Cancer Sci. 2015;106:1738\u201343.","journal-title":"Cancer Sci"},{"key":"1213_CR12","doi-asserted-by":"publisher","first-page":"e206628","DOI":"10.1001\/jamanetworkopen.2020.6628","volume":"3","author":"Y Guo","year":"2020","unstructured":"Guo Y, Li ZX, Zhang JY, Ma JL, Zhang L, Zhang Y, et al. Association between lifestyle factors, vitamin and garlic supplementation, and gastric cancer outcomes: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2020;3:e206628.","journal-title":"JAMA Netw Open"},{"key":"1213_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/GRF.0000000000000027","volume":"57","author":"DM Harper","year":"2014","unstructured":"Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention. Clin Obstet Gynecol. 2014;57:256\u201378.","journal-title":"Clin Obstet Gynecol"},{"issue":"Suppl 5","key":"1213_CR14","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, et al. The burden of human papillomavirus infections and related diseases in Sub-Saharan Africa. Vaccine. 2013;31(Suppl 5):F32-46.","journal-title":"Vaccine"},{"key":"1213_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/ecc.12444","volume":"26","author":"JN Lim","year":"2017","unstructured":"Lim JN, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017;26:526.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"1213_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15:333\u201348.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1213_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2188\/jea.JE20140148","volume":"26","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, Zheng R, He Y, Sun X, Wang N, Chen T, et al. Risk factors for pancreatic cancer in China: a multicenter case-control study. J Epidemiol. 2016;26:64\u201370.","journal-title":"J Epidemiol"},{"key":"1213_CR18","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1001\/archinte.1996.00440180119015","volume":"156","author":"CS Fuchs","year":"1996","unstructured":"Fuchs CS, Colditz GA, Stampfer MJ, Giovannucci EL, Hunter DJ, Rimm EB, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255\u201360.","journal-title":"Arch Intern Med"},{"key":"1213_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MPA.0000000000000251","volume":"44","author":"V Rosato","year":"2015","unstructured":"Rosato V, Polesel J, Bosetti C, Serraino D, Negri E, La Vecchia C. Population attributable risk for pancreatic cancer in Northern Italy. Pancreas. 2015;44:216\u201320.","journal-title":"Pancreas"},{"key":"1213_CR20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jama.1995.03520440059037","volume":"273","author":"J Everhart","year":"1995","unstructured":"Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995;273:1605\u20139.","journal-title":"JAMA"},{"key":"1213_CR21","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/S2468-1253(19)30347-4","volume":"4","author":"GBD 2017 Pancreatic Cancer Collaborators","year":"2019","unstructured":"GBD 2017 Pancreatic Cancer Collaborators. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2019;4:934\u201347.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1213_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mc.20779","volume":"51","author":"G Andreotti","year":"2012","unstructured":"Andreotti G, Silverman DT. Occupational risk factors and pancreatic cancer: a review of recent findings. Mol Carcinog. 2012;51:98\u2013108.","journal-title":"Mol Carcinog"},{"key":"1213_CR23","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/s41395-018-0194-5","volume":"113","author":"CA Shelton","year":"2018","unstructured":"Shelton CA, Umapathy C, Stello K, Yadav D, Whitcomb DC. Hereditary pancreatitis in the United States: survival and rates of pancreatic cancer. Am J Gastroenterol. 2018;113:1376.","journal-title":"Am J Gastroenterol"},{"key":"1213_CR24","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkegard","year":"2017","unstructured":"Kirkegard J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112:1366\u201372.","journal-title":"Am J Gastroenterol"},{"key":"1213_CR25","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/ijc.32406","volume":"146","author":"WY Joko-Fru","year":"2020","unstructured":"Joko-Fru WY, Miranda-Filho A, Soerjomataram I, Egue M, Akele-Akpo MT, N\u2019da G, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: a population-based registry study. Int J Cancer. 2020;146:1208\u201318.","journal-title":"Int J Cancer"},{"key":"1213_CR26","doi-asserted-by":"publisher","first-page":"e0203469","DOI":"10.1371\/journal.pone.0203469","volume":"13","author":"MM Tan","year":"2018","unstructured":"Tan MM, Ho WK, Yoon SY, Mariapun S, Hasan SN, Lee DS, et al. A case-control study of breast cancer risk factors in 7,663 women in Malaysia. PLoS ONE. 2018;13:e0203469.","journal-title":"PLoS ONE"},{"key":"1213_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13058-019-1244-7","volume":"22","author":"AK Heath","year":"2020","unstructured":"Heath AK, Muller DC, van den Brandt PA, Papadimitriou N, Critselis E, Gunter M, et al. Nutrient-wide association study of 92 foods and nutrients and breast cancer risk. Breast Cancer Res. 2020;22:5.","journal-title":"Breast Cancer Res"},{"key":"1213_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3126\/nje.v9i4.26961","volume":"9","author":"PJ Shetty","year":"2019","unstructured":"Shetty PJ, Sreedharan J. Breast cancer and dietary fat intake: a correlational study. Nepal J Epidemiol. 2019;9:812\u20136.","journal-title":"Nepal J Epidemiol"},{"key":"1213_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/sajc.sajc_157_16","volume":"6","author":"P Thakur","year":"2017","unstructured":"Thakur P, Seam RK, Gupta MK, Gupta M, Sharma M, Fotedar V. Breast cancer risk factor evaluation in a Western Himalayan state: a case-control study and comparison with the Western World. South Asian J Cancer. 2017;6:106\u20139.","journal-title":"South Asian J Cancer"},{"key":"1213_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1001\/jamaoncol.2016.6326","volume":"3","author":"NJ Engmann","year":"2017","unstructured":"Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K, Breast Cancer Surveillance Center. Population-attributable risk proportion of clinical risk factors for breast cancer. JAMA Oncol. 2017;3:1228\u201336.","journal-title":"JAMA Oncol"},{"key":"1213_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/M18-1323","volume":"170","author":"HB Nichols","year":"2019","unstructured":"Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, et al. Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med. 2019;170:22\u201330.","journal-title":"Ann Intern Med"},{"key":"1213_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-019-1096-1","volume":"21","author":"Y Xiao","year":"2019","unstructured":"Xiao Y, Xia J, Li L, Ke Y, Cheng J, Xie Y, et al. Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies. Breast Cancer Res. 2019;21:1\u201322.","journal-title":"Breast Cancer Res"},{"key":"1213_CR33","doi-asserted-by":"publisher","first-page":"7365","DOI":"10.1038\/sj.onc.1205798","volume":"21","author":"MC Alavanja","year":"2002","unstructured":"Alavanja MC. Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventions. Oncogene. 2002;21:7365\u201375.","journal-title":"Oncogene"},{"key":"1213_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bmjgh-2020-002788","volume":"5","author":"Z Wang","year":"2020","unstructured":"Wang Z, Hu L, Li J, Wei L, Zhang J, Zhou J. Magnitude, temporal trends and inequality in global burden of tracheal, bronchus and lung cancer: findings from the Global Burden of Disease Study 2017. BMJ Glob Health. 2020;5:89.","journal-title":"BMJ Glob Health"},{"key":"1213_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/thoraxjnl-2019-213722","volume":"75","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Zhu D, Cui B, Ding R, Shi X, He P. Association between particulate matter air pollution and lung cancer. Thorax. 2020;75:85\u20137.","journal-title":"Thorax"},{"key":"1213_CR36","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.15585\/mmwr.mm6845a2","volume":"68","author":"MR Creamer","year":"2019","unstructured":"Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, et al. Tobacco product use and cessation indicators among adults\u2014United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:1013\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1213_CR37","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1047-2797(00)00086-7","volume":"10","author":"R Kleinerman","year":"2000","unstructured":"Kleinerman R, Wang Z, Lubin J, Zhang S, Metayer C, Brenner A. Lung cancer and indoor air pollution in rural china. Ann Epidemiol. 2000;10:469.","journal-title":"Ann Epidemiol"},{"key":"1213_CR38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10552-012-0130-8","volume":"24","author":"L Mu","year":"2013","unstructured":"Mu L, Liu L, Niu R, Zhao B, Shi J, Li Y, et al. Indoor air pollution and risk of lung cancer among Chinese female non-smokers. Cancer Causes Control. 2013;24:439\u201350.","journal-title":"Cancer Causes Control"},{"key":"1213_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-020-00915-0","volume":"13","author":"Y Deng","year":"2020","unstructured":"Deng Y, Zhao P, Zhou L, Xiang D, Hu J, Liu Y, et al. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study. J Hematol Oncol. 2020;13:98.","journal-title":"J Hematol Oncol"},{"key":"1213_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-020-00908-z","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K. The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017. J Hematol Oncol. 2020;13:72.","journal-title":"J Hematol Oncol"},{"key":"1213_CR41","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.arcmed.2016.11.017","volume":"47","author":"J Schuz","year":"2016","unstructured":"Schuz J, Erdmann F. Environmental exposure and risk of childhood Leukemia: an overview. Arch Med Res. 2016;47:607\u201314.","journal-title":"Arch Med Res"},{"key":"1213_CR42","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7314\/APJCP.2014.15.2.781","volume":"15","author":"A Kumar","year":"2014","unstructured":"Kumar A, Vashist M, Rathee R. Maternal factors and risk of childhood leukemia. Asian Pac J Cancer Prev. 2014;15:781\u20134.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1213_CR43","first-page":"3696","volume":"51","author":"M Zack","year":"1991","unstructured":"Zack M, Adami HO, Ericson A. Maternal and perinatal risk factors for childhood leukemia. Cancer Res. 1991;51:3696\u2013701.","journal-title":"Cancer Res"},{"key":"1213_CR44","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1002\/ajh.23744","volume":"89","author":"S Fircanis","year":"2014","unstructured":"Fircanis S, Merriam P, Khan N, Castillo JJ. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies. Am J Hematol. 2014;89:E125-132.","journal-title":"Am J Hematol"},{"key":"1213_CR45","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/sj.leu.2404698","volume":"21","author":"MA Lichtman","year":"2007","unstructured":"Lichtman MA. Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia. Leukemia. 2007;21:1137\u201340.","journal-title":"Leukemia"},{"key":"1213_CR46","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/annonc\/mdf269","volume":"13","author":"Y Chelghoum","year":"2002","unstructured":"Chelghoum Y, Danaila C, Belhabri A, Charrin C, Le QH, Michallet M, et al. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia. Ann Oncol. 2002;13:1621\u20137.","journal-title":"Ann Oncol"},{"key":"1213_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.envres.2017.03.001","volume":"156","author":"RB Gunier","year":"2017","unstructured":"Gunier RB, Kang A, Hammond SK, Reinier K, Lea CS, Chang JS, et al. A task-based assessment of parental occupational exposure to pesticides and childhood acute lymphoblastic leukemia. Environ Res. 2017;156:57\u201362.","journal-title":"Environ Res"},{"key":"1213_CR48","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.leukres.2013.12.008","volume":"38","author":"L Zhao","year":"2014","unstructured":"Zhao L, Liu X, Wang C, Yan K, Lin X, Li S, et al. Magnetic fields exposure and childhood leukemia risk: a meta-analysis based on 11,699 cases and 13,194 controls. Leuk Res. 2014;38:269\u201374.","journal-title":"Leuk Res"},{"key":"1213_CR49","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.envres.2014.04.033","volume":"133","author":"NC Deziel","year":"2014","unstructured":"Deziel NC, Rull RP, Colt JS, Reynolds P, Whitehead TP, Gunier RB, et al. Polycyclic aromatic hydrocarbons in residential dust and risk of childhood acute lymphoblastic leukemia. Environ Res. 2014;133:388\u201395.","journal-title":"Environ Res"},{"key":"1213_CR50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/carcin\/bgu229","volume":"36","author":"Q Lan","year":"2015","unstructured":"Lan Q, Smith MT, Tang X, Guo W, Vermeulen R, Ji Z, et al. Chromosome-wide aneuploidy study of cultured circulating myeloid progenitor cells from workers occupationally exposed to formaldehyde. Carcinogenesis. 2015;36:160\u20137.","journal-title":"Carcinogenesis"},{"key":"1213_CR51","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.gie.2018.04.2352","volume":"88","author":"DC Codipilly","year":"2018","unstructured":"Codipilly DC, Qin Y, Dawsey SM, Kisiel J, Topazian M, Ahlquist D, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88:413\u201326.","journal-title":"Gastrointest Endosc"},{"key":"1213_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2016.06.02","volume":"28","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Zuo T, Zeng H, Zhang S, He J. National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016;28:1\u201311.","journal-title":"Chin J Cancer Res"},{"key":"1213_CR53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7326\/M17-2000","volume":"168","author":"C Yu","year":"2018","unstructured":"Yu C, Tang H, Guo Y, Bian Z, Yang L, Chen Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 2018;168:489\u201397.","journal-title":"Ann Intern Med"},{"key":"1213_CR54","doi-asserted-by":"publisher","first-page":"E470","DOI":"10.1002\/ijc.29224","volume":"136","author":"NI Somdyala","year":"2015","unstructured":"Somdyala NI, Parkin DM, Sithole N, Bradshaw D. Trends in cancer incidence in rural Eastern Cape Province; South Africa, 1998\u20132012. Int J Cancer. 2015;136:E470-474.","journal-title":"Int J Cancer"},{"key":"1213_CR55","doi-asserted-by":"publisher","first-page":"6875","DOI":"10.1002\/cam4.3338","volume":"9","author":"J Fan","year":"2020","unstructured":"Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, et al. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med. 2020;9:6875\u201387.","journal-title":"Cancer Med"},{"key":"1213_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13045-020-00981-4","volume":"13","author":"S Yang","year":"2020","unstructured":"Yang S, Lin S, Li N, Deng Y, Wang M, Xiang D, et al. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol. 2020;13:146.","journal-title":"J Hematol Oncol"},{"key":"1213_CR57","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S2468-1253(20)30007-8","volume":"5","author":"GBD 2017 Oesophageal Cancer Collaborators","year":"2020","unstructured":"GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:582\u201397.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1213_CR58","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1053\/j.gastro.2005.08.053","volume":"129","author":"J Ronkainen","year":"2005","unstructured":"Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, et al. Prevalence of Barrett\u2019s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825\u201331.","journal-title":"Gastroenterology"},{"key":"1213_CR59","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1440-1746.2011.06669.x","volume":"26","author":"KY Ho","year":"2011","unstructured":"Ho KY. From GERD to Barrett\u2019s esophagus: is the pattern in Asia mirroring that in the West? J Gastroenterol Hepatol. 2011;26:816\u201324.","journal-title":"J Gastroenterol Hepatol"},{"key":"1213_CR60","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.cgh.2015.07.050","volume":"13","author":"S Shiota","year":"2015","unstructured":"Shiota S, Singh S, Anshasi A, El-Serag HB. Prevalence of Barrett\u2019s esophagus in Asian countries: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13:1907\u201318.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1213_CR61","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.3748\/wjg.v21.i26.7933","volume":"21","author":"MJ Domper Arnal","year":"2015","unstructured":"Domper Arnal MJ, Ferrandez Arenas A, Lanas AA. Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933\u201343.","journal-title":"World J Gastroenterol"},{"key":"1213_CR62","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S0140-6736(15)00135-X","volume":"386","author":"F Bray","year":"2015","unstructured":"Bray F, Soerjomataram I, Mery L, Ferlay J. Improving the quality and coverage of cancer registries globally. Lancet. 2015;386:1035\u20136.","journal-title":"Lancet"},{"key":"1213_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00038-017-0999-9","volume":"63","author":"R Saran","year":"2018","unstructured":"Saran R. Burden of cancer in the Eastern Mediterranean Region, 2005\u20132015: findings from the Global Burden of Disease 2015 Study. Int J Public Health. 2018;63:151\u201364.","journal-title":"Int J Public Health"},{"key":"1213_CR64","doi-asserted-by":"publisher","first-page":"e663","DOI":"10.1016\/S1470-2045(18)30839-8","volume":"19","author":"B Thomas","year":"2018","unstructured":"Thomas B. Cancer trends and burden in India. Lancet Oncol. 2018;19:e663.","journal-title":"Lancet Oncol"},{"key":"1213_CR65","first-page":"3265","volume":"17","author":"HM Vardanjani","year":"2016","unstructured":"Vardanjani HM, Heidari M, Hadipour M. Can we rely on GLOBOCAN and GBD cancer estimates? Case study of lung cancer incidence and mortality rates and trends in Iran. Asian Pac J Cancer Prev. 2016;17:3265\u20139.","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-021-01213-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-021-01213-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-021-01213-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T13:46:11Z","timestamp":1720791971000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-021-01213-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1213"],"URL":"https:\/\/doi.org\/10.1186\/s13045-021-01213-z","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,22]]},"assertion":[{"value":"16 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}